News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,356 Results
Type
Article (87459)
Company Profile (760)
Press Release (773116)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233063)
Career Advice (4140)
Deals (39797)
Drug Delivery (138)
Drug Development (91257)
Employer Resources (203)
FDA (18285)
Job Trends (17402)
News (397417)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (126)
Alliances (56980)
ALS (146)
Alzheimer's disease (1683)
Antibody-drug conjugate (ADC) (254)
Approvals (18315)
Artificial intelligence (499)
Autoimmune disease (80)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (484)
Bladder cancer (135)
Brain cancer (53)
Breast cancer (513)
Cancer (4022)
Cardiovascular disease (341)
Career advice (3560)
Career pathing (38)
CAR-T (247)
CDC (57)
Cell therapy (689)
Cervical cancer (33)
Clinical research (75600)
Collaboration (1404)
Company closure (4)
Compensation (940)
Complete response letters (60)
COVID-19 (2959)
CRISPR (81)
C-suite (600)
Cystic fibrosis (138)
Data (4588)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (455)
Diagnostics (7095)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (238)
Drug pricing (191)
Drug shortages (36)
Duchenne muscular dystrophy (204)
Earnings (98885)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133093)
Executive appointments (994)
FDA (20785)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1269)
Gene editing (173)
Generative AI (50)
Gene therapy (549)
GLP-1 (1023)
Government (5386)
Grass and pollen (7)
Guidances (349)
Healthcare (20938)
HIV (48)
Huntington's disease (38)
IgA nephropathy (64)
Immunology and inflammation (244)
Immuno-oncology (21)
Indications (53)
Infectious disease (3205)
Inflammatory bowel disease (188)
Inflation Reduction Act (16)
Influenza (101)
Intellectual property (192)
Interviews (816)
IPO (17927)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (79)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (579)
Lymphoma (267)
Machine learning (31)
Management (66)
Manufacturing (644)
MASH (141)
Medical device (14878)
Medtech (14903)
Mergers & acquisitions (22754)
Metabolic disorders (1164)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (230)
Neuropsychiatric disorders (62)
Neuroscience (2728)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (58)
Obesity (563)
Opinion (314)
Ovarian cancer (136)
Pain (167)
Pancreatic cancer (172)
Parkinson's disease (243)
Partnered (30)
Patents (423)
Patient recruitment (322)
Peanut (57)
People (66292)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23320)
Phase II (32816)
Phase III (24725)
Pipeline (2750)
Policy (295)
Postmarket research (3554)
Preclinical (10517)
Press Release (72)
Prostate cancer (201)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (681)
Real estate (7422)
Recruiting (79)
Regulatory (28046)
Reports (65)
Research institute (2692)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (73)
Schizophrenia (137)
Series A (211)
Series B (158)
Service/supplier (30)
Sickle cell disease (81)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (96)
The Weekly (110)
Vaccines (1054)
Venture capital (67)
Weight loss (397)
Women's health (59)
Worklife (21)
Date
Today (106)
Last 7 days (747)
Last 30 days (2707)
Last 365 days (33623)
2025 (26892)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (304)
Arkansas (14)
Asia (51003)
Australia (8963)
California (9552)
Canada (2884)
China (914)
Colorado (405)
Connecticut (427)
Delaware (271)
Europe (117173)
Florida (1404)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (814)
India (52)
Indiana (466)
Iowa (20)
Japan (327)
Kansas (125)
Kentucky (38)
Louisiana (21)
Maine (78)
Maryland (1289)
Massachusetts (7169)
Michigan (315)
Minnesota (566)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2650)
New Mexico (32)
New York (2596)
North Carolina (1421)
North Dakota (10)
Northern California (4341)
Ohio (300)
Oklahoma (22)
Oregon (50)
Pennsylvania (1985)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3644)
Tennessee (150)
Texas (1498)
United States (35261)
Utah (283)
Virginia (250)
Washington D.C. (84)
Washington State (824)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,356 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference
October 24, 2025
·
9 min read
Press Releases
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
October 24, 2025
·
5 min read
Press Releases
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
October 24, 2025
·
1 min read
Press Releases
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance
October 24, 2025
·
4 min read
Press Releases
Abolis Biotechnologies and EUROAPI Enter Into Partnership to Accelerate Pharmaceutical Innovation and Restore European Sovereignty
October 24, 2025
·
4 min read
Press Releases
Moderna Named a Top Employer by Science for Eleventh Consecutive Year
October 24, 2025
·
3 min read
Press Releases
Zenocutuzumab-zbco Granted FDA Breakthrough Therapy Designation for NRG1+ Cholangiocarcinoma; Data Highlighting Potential of Zenocutuzumab-zbco in NRG1+ Cholangiocarcinoma to be Presented at AACR-NCI-EORTC
October 24, 2025
·
12 min read
Press Releases
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
October 24, 2025
·
7 min read
Press Releases
Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 24, 2025
·
3 min read
Press Releases
CDR-Life Presents Early Clinical Data Demonstrating Pharmacodynamic Activity of CDR404, a Novel Antibody-Derived T Cell Engager Targeting MAGE-A4+ Solid Tumors
October 23, 2025
·
3 min read
1 of 86,136
Next
